<DOC>
	<DOCNO>NCT02333279</DOCNO>
	<brief_summary>The investigator determine cancer risk organ transplant recipient compare general population help statistical analysis . Secondly investigator try characterize different cancer type .</brief_summary>
	<brief_title>Cancer Development In Organ Transplant Recipients</brief_title>
	<detailed_description>This cohort analyse focus incident recurrent case development non-skin cancer time . We consider time first formation non-skin solid cancer solid organ transplantation well cumulative number non-skin solid cancer formation time . Both aspect equally important reflect analytic method study . Theses analysis restrict prevalent transplantation type heart , kidney , liver , lung .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Heart Neoplasms</mesh_term>
	<criteria>We select patient within STCS base date first solid organ transplantation . Patients multiple organ transplantation include well . Patients contribute study observation time death end followup due reason . We exclude patient nonsolid organ transplantation ( e.g . hematopoietic stem cell transplantation ) , detail information STCS insufficient allow detail analysis cancer development control relevant confounders . We exclude</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>